Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Terumo Corp. (OTC: TRUMY).

Full DD Report for TRUMY

You must become a subscriber to view this report.


Recent News from (OTC: TRUMY)

Terumo Cardiovascular Group Announces 510(k) Clearance for the CDI® Blood Parameter Monitoring System 550, Adding New Parameter for Oxygen Delivery
ANN ARBOR, Mich. , Nov. 14, 2018 /PRNewswire/ -- Terumo Cardiovascular Group, a global leader in cardiovascular surgery technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the CDI ® Blood Parameter Monitoring System 55...
Source: PR Newswire
Date: November, 14 2018 11:00
Terumo Corp. ADR 2019 Q1 - Results - Earnings Call Slides
The following slide deck was published by Terumo Corp. ADR in conjunction with their 2019 Q1 earnings Read more ...
Source: SeekingAlpha
Date: August, 09 2018 13:36
Week In Review: Long Hill Capital Closes $265 Million Fund For China Healthcare
Deals and Financings Long Hill Capital of Beijing and Shanghai, which is focused on investments in the healthcare and consumer sectors, closed its second fund at $265 million. The firm's first fund raised $125 million in 2016. Long Hill said the new fund "significantly exceeded" its original...
Source: SeekingAlpha
Date: July, 29 2018 13:48
MicroVention Announces FDA Clearance For Thrombectomy Device
ALISO VIEJO, Calif. , June 12, 2018 /PRNewswire/ -- MicroVention, Inc. a U.S.-based subsidiary of Terumo and a global neurovascular company, announced today the FDA clearance of a new clinical indication for the SOFIA ® Catheter ( S oft T O rqueable catheter F or I ntracr...
Source: PR Newswire
Date: June, 12 2018 07:00
MicroVention® Announces FDA Approval For Neuro Stent Device
ALISO VIEJO, Calif. , May 31, 2018 /PRNewswire/ -- MicroVention, Inc., a U.S.-based subsidiary of Terumo and a global neurovascular company, announced today the FDA Premarket Approval (PMA) for the LVIS ® and LVIS ® Jr. stents for stent-assisted coil embolization of intrac...
Source: PR Newswire
Date: May, 31 2018 10:00
Medeon Entering Asset Purchase Agreement with Terumo for its Large Bore Vascular Closure System
TAIPEI, Taiwan , March 5, 2018 /PRNewswire/ -- Medeon Biodesign, Inc. (TPEx: 6499), a Taiwan publicly traded medical device company, is pleased to announce today that it entered into a definitive asset purchase agreement with Tokyo -based Terumo Corporation (TSE: 4543) for its large bo...
Source: PR Newswire
Date: March, 05 2018 02:00
Terumo Corp. ADR 2018 Q3 - Results - Earnings Call Slides
The following slide deck was published by Terumo Corp. ADR in conjunction with their 2018 Q3 earnings Read more ...
Source: SeekingAlpha
Date: February, 09 2018 15:13
MicroVention Celebrates Grand Opening Of New Worldwide Innovation Center In Aliso Viejo, California
ALISO VIEJO, Calif. , Sept. 26, 2017 /PRNewswire/ -- MicroVention, a wholly owned subsidiary of Terumo Corporation and a global neurovascular company, today announced that the Grand Opening of its New Innovation Center was held on Monday, September 25. The opening of the new fac...
Source: PR Newswire
Date: September, 26 2017 10:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-14N/A53.89N/AN/A41
2018-12-13N/A53.89N/AN/A110
2018-12-12N/A53.89N/AN/A170
2018-12-11N/A53.89N/AN/A0
2018-12-10N/A53.89N/AN/A68

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-11-295251,10947.3399Short
2018-11-261,0502,21647.3827Short
2018-11-1677100.0000Short
2018-11-14415377.3585Short
2018-11-1334063053.9683Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on TRUMY.


About Terumo Corp. (OTC: TRUMY)

Logo for Terumo Corp. (OTC: TRUMY)

In the world of medical devices and supplies, the cornerstones of excellence are dependability, predictability, and consistency. To ensure that every item we manufacture meets these criteria, Terumo Medical Corporation applies strict standards of quality control. lt br / gt lt br / gt By developing innovative, high quality medical products that the healthcare community can rely on, Terumo Medical Corporation realizes its goal of Contributing to Society Through Healthcare.

 

Contact Information

 

 

Current Management

  • Kazuaki Kitabatake / CEO
  • Koji Nakao / Chairman

Current Share Structure

     


    Recent Filings from (OTC: TRUMY)

    Post-effective amendment to a previously filed F-6
    Filing Type: F-6 POSFiling Source: edgar
    Filing Date: September, 29 2017

     

     


    Daily Technical Chart for (OTC: TRUMY)

    Daily Technical Chart for (OTC: TRUMY)


    Stay tuned for daily updates and more on (OTC: TRUMY)

    It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

    More to come on (OTC: TRUMY)

    Do your DD and if you choose, be ready to go!


     

    The Research: All source information contained in this email is from the public sources mentioned below.

     

     
     

    Thank you

    DD Report
    @DDReports

     

     


    Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in TRUMY is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of TRUMY and does not buy, sell, or trade any shares of TRUMY. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/